Financials 1CM Inc.

Equities

EPIC

CA68237A1093

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:59:33 2024-04-26 pm EDT 5-day change 1st Jan Change
1 CAD 0.00% Intraday chart for 1CM Inc. 0.00% -34.21%

Valuation

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Capitalization 1 144 30.32 15.68 57.63 117.1 218.5
Enterprise Value (EV) 1 144.6 33.09 25.75 69.72 126 221.8
P/E ratio -12.1 x -0.95 x -5.56 x -12.6 x -23.4 x -238 x
Yield - - - - - -
Capitalization / Revenue 1,751 x 256 x 216 x 93.8 x 139 x 6.18 x
EV / Revenue 1,758 x 279 x 354 x 114 x 150 x 6.28 x
EV / EBITDA -23.2 x -11 x -12 x -18.1 x -38 x 217 x
EV / FCF 82.4 x -9.61 x -5.46 x -121 x -40.9 x -54.9 x
FCF Yield 1.21% -10.4% -18.3% -0.83% -2.45% -1.82%
Price to Book 3.45 x 23.2 x -11.6 x -15 x 8.9 x 8.88 x
Nbr of stocks (in thousands) 94,744 94,744 84,744 84,744 94,404 114,404
Reference price 2 1.520 0.3200 0.1850 0.6800 1.240 1.910
Announcement Date 1/31/19 12/30/19 12/23/20 12/24/21 12/28/22 12/29/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net sales 1 0.0823 0.1185 0.0727 0.6141 0.8425 35.34
EBITDA 1 -6.226 -2.995 -2.15 -3.846 -3.315 1.02
EBIT 1 -6.235 -2.999 -2.153 -4.472 -3.945 0.3732
Operating Margin -7,579.5% -2,530.49% -2,960.58% -728.21% -468.3% 1.06%
Earnings before Tax (EBT) 1 -6.378 -28.56 -3.029 -4.915 -4.995 -0.5618
Net income 1 -6.378 -28.53 -2.818 -4.558 -4.727 -0.9139
Net margin -7,753.26% -24,074.18% -3,873.96% -742.22% -561.1% -2.59%
EPS 2 -0.1254 -0.3366 -0.0332 -0.0538 -0.0531 -0.008041
Free Cash Flow 1 1.756 -3.445 -4.716 -0.5785 -3.081 -4.044
FCF margin 2,134.15% -2,906.83% -6,484.51% -94.2% -365.73% -11.44%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 1/31/19 12/30/19 12/23/20 12/24/21 12/28/22 12/29/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: August 2018 2019 2020 2021 2022 2023
Net Debt 1 0.58 2.77 10.1 12.1 8.9 3.32
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.0931 x -0.9247 x -4.686 x -3.146 x -2.684 x 3.249 x
Free Cash Flow 1 1.76 -3.44 -4.72 -0.58 -3.08 -4.04
ROE (net income / shareholders' equity) -32.1% -139% 1,294% 162% -91.4% -4.57%
ROA (Net income/ Total Assets) -17.4% -7.48% -17.8% -29.1% -13.1% 0.75%
Assets 1 36.74 381.5 15.85 15.66 36 -121.9
Book Value Per Share 2 0.4400 0.0100 -0.0200 -0.0500 0.1400 0.2100
Cash Flow per Share 2 0.0300 0.0100 0 0 0.0200 0.0300
Capex - 1.08 3.7 0.01 0.22 2.01
Capex / Sales - 915.37% 5,086.76% 2.2% 25.93% 5.68%
Announcement Date 1/31/19 12/30/19 12/23/20 12/24/21 12/28/22 12/29/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA